Log in

M&ACNBC-TV18

AstraZeneca India signs LoI with Reliance's Strand

Positive+67

GreyOak summary

AstraZeneca Pharma India signed a letter of intent with Strand Life Sciences, a Reliance subsidiary, to explore healthcare collaboration opportunities. The deal does not specify the partnership scope. AstraZeneca shares rose 2.4% following the announcement, which comes after the company reported a 14.9% increase in Q2 net profit.

What it affects

Source

Read the original at CNBC-TV18

More AstraZeneca Pharma India news

No other recent stories about AstraZeneca Pharma India.

All AstraZeneca Pharma India news →

We use cookies

Essential cookies keep GreyOak secure and functional. Optional cookies help improve your experience and platform performance. You can update your preferences anytime.

Cookie Policy